Neal Chatterjee, MD
Clinical Cardiac Electrophysiology · Seattle, WANPI 1669792032
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (39.3%), grants and consulting fees — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Sanofi-aventis U.S. LLC at 44.7% of the total. Reporting peaked in 2019 at $7,379 and has fallen 65.6% since, to $2,535 in 2024.
Across 14 payments — averaging $1582.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$10K
- Medtronic$6K
- Siemens Medical Solutions USA, Inc.$5K
- Boston Scientific$1K
- Biosense Webster, Inc.$131
Across 4 payments — averaging $4709.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$19K
What the payments were for
- Consulting fees$6,03827%
- Speaking & faculty fees$8,71039%
- Grants$7,08332%
- Food & beverage$3171%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 3 | $9,893 |
| Medtronic | 5 | $6,019 |
| Siemens Medical Solutions USA, Inc. | 3 | $4,855 |
| Boston Scientific | 1 | $1,250 |
| Biosense Webster, Inc. | 2 | $131 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MULTAQ$2,343
- GENERAL BRADY$1,250
- SC2000$1,160
- ACUSON Sequoia Diagnostic Ultrasound System$1,160
- Pentaray$109
How this compares
$22,148 in reported general payments places this provider in the 70th percentile of 68 clinical cardiac electrophysiology providers in Washington.
See all clinical cardiac electrophysiology providers in Washington →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 143 | $194,708 |
| MultaqDronedarone Hcl | 26 | $40,586 |
| Mexiletine Hcl | 21 | $3,438 |
| Amiodarone Hcl | 58 | $2,786 |
| Flecainide Acetate | 25 | $2,532 |
| Metoprolol Succinate | 93 | $1,299 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 24 | $1,153 |
| SotalolSotalol Hcl | 33 | $838 |
| Nadolol | 12 | $621 |
| Carvedilol | 13 | $89 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sanofi-aventis U.S. LLCMultaq | $9,893 | $40,58626 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 68 clinical cardiac electrophysiology providers in Washington.
Other clinical cardiac electrophysiology in Seattle
- Gust BardySeattle$130.7M
- Babak NazerSeattle$124K
- Toshimasa OkabeSeattle$114K
- Darryl WellsSeattle$112K
- Arun R Mahankali SridharSeattle$94K
- Jeanne PooleSeattle$81K
- David RosenthalSeattle$54K
- Eathar RazakSeattle$50K
- Uyanga BatnyamSeattle$38K
- Carlos AlvesSeattle$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.